Cargando…
High mortality from neo-adjuvant chemo-radiotherapy for rectal cancer needs to be evaluated against the alternative of adjuvant therapy
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2006
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360526/ https://www.ncbi.nlm.nih.gov/pubmed/17016488 http://dx.doi.org/10.1038/sj.bjc.6603338 |
| _version_ | 1782153071333212160 |
|---|---|
| author | Papagrigoriadis, S |
| author_facet | Papagrigoriadis, S |
| author_sort | Papagrigoriadis, S |
| collection | PubMed |
| description | |
| format | Text |
| id | pubmed-2360526 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2006 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-23605262009-09-10 High mortality from neo-adjuvant chemo-radiotherapy for rectal cancer needs to be evaluated against the alternative of adjuvant therapy Papagrigoriadis, S Br J Cancer Letter to the Editor Nature Publishing Group 2006-10-09 2006-10-03 /pmc/articles/PMC2360526/ /pubmed/17016488 http://dx.doi.org/10.1038/sj.bjc.6603338 Text en Copyright © 2006 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Letter to the Editor Papagrigoriadis, S High mortality from neo-adjuvant chemo-radiotherapy for rectal cancer needs to be evaluated against the alternative of adjuvant therapy |
| title | High mortality from neo-adjuvant chemo-radiotherapy for rectal cancer needs to be evaluated against the alternative of adjuvant therapy |
| title_full | High mortality from neo-adjuvant chemo-radiotherapy for rectal cancer needs to be evaluated against the alternative of adjuvant therapy |
| title_fullStr | High mortality from neo-adjuvant chemo-radiotherapy for rectal cancer needs to be evaluated against the alternative of adjuvant therapy |
| title_full_unstemmed | High mortality from neo-adjuvant chemo-radiotherapy for rectal cancer needs to be evaluated against the alternative of adjuvant therapy |
| title_short | High mortality from neo-adjuvant chemo-radiotherapy for rectal cancer needs to be evaluated against the alternative of adjuvant therapy |
| title_sort | high mortality from neo-adjuvant chemo-radiotherapy for rectal cancer needs to be evaluated against the alternative of adjuvant therapy |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360526/ https://www.ncbi.nlm.nih.gov/pubmed/17016488 http://dx.doi.org/10.1038/sj.bjc.6603338 |
| work_keys_str_mv | AT papagrigoriadiss highmortalityfromneoadjuvantchemoradiotherapyforrectalcancerneedstobeevaluatedagainstthealternativeofadjuvanttherapy |